meglumine has been researched along with pyridoxal phosphate in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Eibl-Eibesfeldt, B; Hammerstingl, R; Lissner, J; Peqios, W; Schnell, B; Vogl, TJ | 1 |
| Berthezène, Y; Brasch, RC; Clément, O; Mühler, A; Rosenau, W; Vexler, V | 1 |
| Peters, PE; Rummeny, EJ | 1 |
| Elizondo, G; Fretz, CJ; Stark, DD | 1 |
| Golman, K; Holtz, E; Klaveness, J; Leander, P; Leunbach, I; Olsson, M | 1 |
| Kopp, AF; Laniado, M | 1 |
| Clément, O; Cuénod, CA; Frija, G; Leconte, I; Siauve, N; Vuillemin-Bodaghi, V | 1 |
| De Cobelli, F; De Gaspari, A; Del Maschio, A | 1 |
| Helmberger, T; Semelka, RC | 1 |
| Reimer, P; Schima, W; Schneider, G | 1 |
| Rummeny, EJ; Settles, M; Weirich, G; Wiener, E; Woertler, K | 1 |
| Catalano, OA; Hahn, PF; Sahani, DV; Saini, S; Seale, MK | 1 |
| Alexander Grant, L; Burke, C; Goh, V; Griffin, N | 1 |
7 review(s) available for meglumine and pyridoxal phosphate
| Article | Year |
|---|---|
[Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Topics: Acetates; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
[Current status of the clinical development of MR contrast media].
Topics: Adult; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections, Intravenous; Iron; Lymphography; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate; Suspensions | 1997 |
Mechanisms of action of liver contrast agents: impact for clinical use.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Injections, Intravenous; Iron; Kupffer Cells; Liver; Liver Diseases; Magnetic Resonance Imaging; Magnetite Nanoparticles; Manganese; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate | 1999 |
[Magnetic resonance imaging of the liver: what kind of contrast agents?].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Iron; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate | 2001 |
New contrast agents for imaging the liver.
Topics: Animals; Contrast Media; Edetic Acid; Ferric Compounds; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2001 |
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Meglumine; Organometallic Compounds; Pyridoxal Phosphate; Time Factors; Tomography, X-Ray Computed | 2004 |
The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Topics: Bile Duct Neoplasms; Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Hepatocytes; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2013 |
1 trial(s) available for meglumine and pyridoxal phosphate
| Article | Year |
|---|---|
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Topics: Biliary Tract Diseases; Biliary Tract Neoplasms; Cholangiography; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1992 |
6 other study(ies) available for meglumine and pyridoxal phosphate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Topics: Acetates; Animals; Bile; Contrast Media; Duodenum; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Gallbladder; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Mice; Models, Statistical; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Time Factors | 1992 |
Liver-specific contrast agents for MRI.
Topics: Acetates; Animals; Contrast Media; Dextrans; Edetic Acid; Ethylenediamines; Ferrosoferric Oxide; Ferrous Compounds; Iron; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Magnetite Nanoparticles; Meglumine; Organometallic Compounds; Oxides; Pyridoxal Phosphate; Rats | 1990 |
MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction.
Topics: Animals; Cholestasis; Chromium; Contrast Media; Edetic Acid; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Male; Manganese; Meglumine; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats; Rats, Inbred Strains | 1990 |
Contrast enhanced cartilage imaging: Comparison of ionic and non-ionic contrast agents.
Topics: Animals; Arthrography; Cartilage, Articular; Cattle; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Patellar Ligament; Pyridoxal Phosphate; Sodium Chloride; Time Factors | 2007 |
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Topics: Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2009 |